$2.00 upon approval it. For those holding long (3 years), pps could get up to $5-8
US alone 55-60 million PAP tests annually 5.5-6 million follow-up referrals
$35-40 disposable with 90% + target margin (22.50 whole sale)
In my opinion, it is an exceedingly naive expectation. And have merci for your calculator by refraining from pestering it with simplistic arithmetics. Life, as always, will have little trouble of showing us where we are. Patience.
No chance. In January of 2012 when the price was 1.75 it was most likely going to go over 3.00. At least in my opinion. But not now with the price being around .70, many more shares out there, warrants, etc. If approved, in the long run, I see no reason why it couldn't easily surpass 3 bucks.
I believe it's possible. But, it's difficult to say due to Luviva not being exchange listed, the existence of the warrants, and any info that may become available between now and then regarding the international market launch...ie - sales dollars, margin details, market reception, etc.